187 related articles for article (PubMed ID: 20614329)
1. Plasmablastic lymphoma in a previously undiagnosed AIDS patient: a case report.
Vieira FO; El Gandour O; Buadi FK; Williams GB; Shires CB; Zafar N
Head Neck Pathol; 2008 Jun; 2(2):92-6. PubMed ID: 20614329
[TBL] [Abstract][Full Text] [Related]
2. Oral plasmablastic lymphoma as the first manifestation of AIDS.
Vale DAD; Rogado CM; Carvalho DLC; Trierveiler M; Ortega KL
An Bras Dermatol; 2017; 92(5 Suppl 1):110-112. PubMed ID: 29267464
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases.
Lester R; Li C; Phillips P; Shenkier TN; Gascoyne RD; Galbraith PF; Vickars LM; Leitch HA
Leuk Lymphoma; 2004 Sep; 45(9):1881-5. PubMed ID: 15223650
[TBL] [Abstract][Full Text] [Related]
4. Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection.
Riedel DJ; Gonzalez-Cuyar LF; Zhao XF; Redfield RR; Gilliam BL
Lancet Infect Dis; 2008 Apr; 8(4):261-7. PubMed ID: 18353267
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated oral plasmablastic lymphoma and role of adherence to highly active antiretroviral therapy.
Francischini E; Martins FM; Braz-Silva PH; Magalhães MH; Ortega KL
Int J STD AIDS; 2010 Jan; 21(1):68-70. PubMed ID: 19884361
[TBL] [Abstract][Full Text] [Related]
6. Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
Atallah-Yunes SA; Murphy D; Abdelmalak R; Mantle L; Ali SS
Eur J Haematol; 2019 Dec; 103(6):620-622. PubMed ID: 31505061
[TBL] [Abstract][Full Text] [Related]
7. Plasmablastic lymphoma of the oral cavity: a review.
Sarode SC; Sarode GS; Patil A
Oral Oncol; 2010 Mar; 46(3):146-53. PubMed ID: 20138565
[TBL] [Abstract][Full Text] [Related]
8. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.
Castillo J; Pantanowitz L; Dezube BJ
Am J Hematol; 2008 Oct; 83(10):804-9. PubMed ID: 18756521
[TBL] [Abstract][Full Text] [Related]
9. Impact of highly active antiretroviral therapy in the development and remission of oral plasmablastic lymphoma.
Wagner VP; Ortiz L; da Silva HP; Meurer L; da Cunha Filho JJ; Martins MA; Martins MD
Indian J Dent Res; 2016; 27(5):559-562. PubMed ID: 27966518
[TBL] [Abstract][Full Text] [Related]
10. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity.
Panos G; Karveli EA; Nikolatou O; Falagas ME
Am J Hematol; 2007 Aug; 82(8):761-5. PubMed ID: 17094093
[TBL] [Abstract][Full Text] [Related]
11. Plasmablastic lymphoma of head and neck: report of two new cases and correlation with c-myc and IgVH gene mutation status.
Hassan A; Kreisel F; Gardner L; Lewis JS; El-Mofty SK
Head Neck Pathol; 2007 Dec; 1(2):150-5. PubMed ID: 20614267
[TBL] [Abstract][Full Text] [Related]
12. Plasmablastic lymphoma of the oral cavity, a B cell-derived lymphoma associated with HIV infection: a case series.
Tsachouridou O; Christoforidou A; Metallidis S; Papaioannou M; Kollaras P; Kolokotronis A; Chrysanthidis T; Pilalas D; Markou K
Eur Arch Otorhinolaryngol; 2012 Jun; 269(6):1713-9. PubMed ID: 22350427
[TBL] [Abstract][Full Text] [Related]
13. Oral plasmablastic lymphoma: A case report.
Zizzo M; Zanelli M; Martiniani R; Sanguedolce F; De Marco L; Martino G; Parente P; Annessi V; Manzini L; Ascani S
Medicine (Baltimore); 2020 Sep; 99(39):e22335. PubMed ID: 32991445
[TBL] [Abstract][Full Text] [Related]
14. Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma.
Gilaberte M; Gallardo F; Bellosillo B; Saballs P; Barranco C; Serrano S; Pujol RM
Br J Dermatol; 2005 Oct; 153(4):828-32. PubMed ID: 16181470
[TBL] [Abstract][Full Text] [Related]
15. Large cell lymphoma: correlation of HIV status and prognosis with differentiation profiles assessed by immunophenotyping.
Pather S; Mohamed Z; McLeod H; Pillay K
Pathol Oncol Res; 2013 Oct; 19(4):695-705. PubMed ID: 23670212
[TBL] [Abstract][Full Text] [Related]
16. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
17. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.
Noy A; Lensing SY; Moore PC; Gupta N; Aboulafia D; Ambinder R; Baiocchi R; Dezube BJ; Henry D; Kaplan L; Levine AM; Mitsuyasu R; Ratner L; Reid E; Remick S; Sparano J; Tzachanis D; Wachsman W; Chadburn A
Leuk Lymphoma; 2016 Jul; 57(7):1731-4. PubMed ID: 26674561
[No Abstract] [Full Text] [Related]
18. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
20. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
